Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic – a clinical effectiveness study

References

• Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473–486.
   PubMed Web of Science ®Google Scholar
• Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917.
   PubMed Web of Science ®Google Scholar
• Spiegel BMR. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11(4):265–269.
   PubMedGoogle Scholar
• Blanchard EB. Irritable bowel syndrome: psychosocial assessment and treatment. Washington (DC): American Psychological Association; 2001.
   Google Scholar
• American Gastroenterological Association. IBS in America: survey summary findings; 2015. Available from: http://www.multivu.com/players/English/7634451-aga-ibs-in-america-survey/docs/survey-findings-pdf-635473172.pdf
   Google Scholar
• Liang AM, Tien Y. Quality of life in irritable bowel syndrome: a narrative overview. J Arch Mil Med. 2016;4(1):e36624.
   Google Scholar
• De Giorgio R, Barbara G, Stanghellini V, et al. Diagnosis and therapy of irritable bowel syndrome. Aliment Pharmacol Therapeut. 2004;20:10–22.
   PubMed Web of Science ®Google Scholar
• Laird KT, Tanner-Smith EE, Russell AC, et al. Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(7):937 .e4–947.e4.
   PubMed Web of Science ®Google Scholar
• Jerndal P, Ringström G, Agerforz P, et al. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil. 2010;22(6):646–e179.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Andréewitch S, Hedman E, et al. Exposure and mindfulness based therapy for irritable bowel syndrome-an open pilot study. J Behav Ther Exp Psychiatry. 2010;41(3):185–190.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Falk L, Vesterlund AW, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome-a randomized controlled trial. Behav Res Ther. 2010;48(6):531–539.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Andersson G, Andersson E, et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11(1):110.
   PubMed Web of Science ®Google Scholar
• Ljotsson B, Hedman E, Andersson E, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106(8):1481–1491.
   PubMed Web of Science ®Google Scholar
• Ljotsson B, Hedman E, Lindfors P, et al. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther. 2011;49(1):58–61.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Hesser H, Andersson E, et al. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behav Res Ther. 2014;55:27–39.
   PubMed Web of Science ®Google Scholar
• Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition . Am J Public Health. 2003;93(8):1261–1267.
   PubMed Web of Science ®Google Scholar
• Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.
   PubMed Web of Science ®Google Scholar
• Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877–883.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Santoft F, Lindsäter E, et al. Predictors of outcome in guided self-help cognitive behavioural therapy for common mental disorders in primary care. Cogn Behav Ther. 2019;20(7):1–20.
   Google Scholar
• Reme SE, Kennedy T, Jones R, et al. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care. J Psychosom Res. 2010;68(4):385–388.
   PubMed Web of Science ®Google Scholar
• Porcelli P, De Carne M, Leandro G. The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome. Compr Psychiatry. 2017;73:127–135.
   PubMed Web of Science ®Google Scholar
• Lackner JM, Jaccard J, Firth R, et al. Factors associated with efficacy of cognitive behavior therapy vs education for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2019;17(8):1500–1508.e3.
   PubMed Web of Science ®Google Scholar
• Blanchard EB, Schwarz SP, Neff DF, et al. Prediction of outcome from the self-regulatory treatment of irritable bowel syndrome. Behav Res Ther. 1988;26(2):187–190.
   PubMed Web of Science ®Google Scholar
• Gonsalkorale W, Houghton L, Whorwell P. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol. 2002;97(4):954–961.
   PubMed Web of Science ®Google Scholar
• Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology. 1991;100(2):450–457.
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut. 1987;28(4):423–425.
   PubMed Web of Science ®Google Scholar
• Wiklund IK, Fullerton S, Hawkey CJ, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2003;38(9):947–954.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Jones M, Talley NJ, et al. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: a population study. United Eur Gastroenterol J. 2020;8(3):284–292.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Drossman DA, Frederick IO, et al. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400–411.
   PubMed Web of Science ®Google Scholar
• Labus JS, Bolus R, Chang L, et al. The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20(1):89–97.
   PubMed Web of Science ®Google Scholar
• Craske MG, Wolitzky-Taylor KB, Labus J, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49(6-7):413–421.
   PubMed Web of Science ®Google Scholar
• Labus JS. In search of mechanisms of change in treatment outcome research: mediators and moderators of psychological and pharmacological treatments for irritable bowel syndrome. Gastroenterology. 2007;133(2):702–705.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Hesser H, Andersson E, et al. Mechanisms of change in an exposure-based treatment for irritable bowel syndrome. J Consult Clin Psychol. 2013;81(6):1113–1126.
   PubMed Web of Science ®Google Scholar
• Wolitzky-Taylor K, Craske MG, Labus JS, et al. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther. 2012;50(10):647–650.
   PubMed Web of Science ®Google Scholar
• Fantino B, Moore N. The self-reported Montgomery-Asberg depression rating scale is a useful evaluative tool in major depressive disorder. BMC Psychiatry. 2009;9(1):26.
   PubMed Web of Science ®Google Scholar
• Holländare F, Andersson G, Engström I. A comparison of psychometric properties between internet and paper versions of two depression instruments (BDI-II and MADRS-S) administered to clinic patients. J Med Internet Res. 2010;12(5):e49.
   PubMed Web of Science ®Google Scholar
• Wallén H, Lindfors P, Andersson E, et al. Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial. BMC Gastroenterol. 2021;21(1):289.
   PubMed Web of Science ®Google Scholar
• Miller V, Carruthers HR, Morris J, et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41(9):844–855.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). Guidance for Industry Irritable Bowel Syndrome - Clinical Evaluation of Drugs for Treatment; 2012 [cited 2021 Dec 2]. Available from: https://www.fda.gov/media/78622/download
   Google Scholar
• Hedman E, Lindefors N, Andersson G, et al. Predictors of outcome in internet-based cognitive behavior therapy for severe health anxiety. Behav Res Ther. 2013;51(10):711–717.
   PubMed Web of Science ®Google Scholar
• Windgassen S, Moss-Morris R, Goldsmith K, et al. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: the importance of gastrointestinal related cognitions, behaviours and general anxiety. J Psychosom Res. 2019;118:73–82.
   PubMed Web of Science ®Google Scholar
• Ljótsson B. What are the mechanisms of psychological treatments for irritable bowel syndrome? J Psychosom Res. 2019;118:9–11.
   PubMed Web of Science ®Google Scholar
• Ballou S, Keefer L. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol. 2017;8(1):e214.
   PubMed Web of Science ®Google Scholar
• Ljótsson B, Andersson E, Lindfors P, et al. Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. BMC Gastroenterol. 2013;13(1):160.
   PubMed Web of Science ®Google Scholar
• Blanchard EB, Lackner JM, Gusmano R, et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behav Res Ther. 2006;44(3):317–337.
   PubMed Web of Science ®Google Scholar
• Hesser H, Hedman-Lagerlöf E, Lindfors P, et al. Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: a secondary analysis of results from a randomized component trial. Behav Res Ther. 2021;141:103862.
   PubMed Web of Science ®Google Scholar